Cigna Investments’s RLX Technology RLX Stock Holding History

Cigna Investments’s Portfolio RLX Stock Details RLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,236	Closed	-$11K	–	458
2022 Q3	$11K	Hold	10,236	–	–	﹤0.01%	431
2022 Q2	$22K	Hold	10,236	–	–	﹤0.01%	455
2022 Q1	$18K	Hold	10,236	–	–	﹤0.01%	591
2021 Q4	$40K	Hold	10,236	–	–	﹤0.01%	651
2021 Q3	$46K	Buy	+10,236	New	+$55.6K	﹤0.01%	736

Other funds holding RLX

ICVCFVA

IDG China Venture Capital Fund V Associates Hong Kong $105M AUM 14.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OPL

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TPC

Tiger Pacific Capital New York $218M AUM 12.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cigna Investments's RLX Position: Q4 2022 in Review

Cigna Investments sold out of RLX Technology (RLX) in Q4 2022, closing a stake of 10,236 shares — an estimated $11K sold.

Cigna Investments first reported a position in RLX in Q3 2021 and held it in 5 quarters. The position peaked at $46K in Q3 2021. 111 funds tracked by Wall St. Rank hold RLX as of Q4 2022.

Cigna Investments reported no remaining RLX Technology position as of Q4 2022 after selling out during the quarter.
Cigna Investments sold 10,236 RLX Technology shares in Q4 2022, an estimated $11K.
Cigna Investments first reported a position in RLX Technology in Q3 2021 and held it in 5 quarters.
Cigna Investments's RLX Technology position peaked at $46K in Q3 2021.
111 funds tracked by Wall St. Rank held RLX Technology as of Q4 2022.

Based on Cigna Investments's 13F filing for Q4 2022, filed 13 Feb 2023.